Compare IMXI & CTKB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IMXI | CTKB |
|---|---|---|
| Founded | 1994 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 469.3M | 541.1M |
| IPO Year | 2016 | 2021 |
| Metric | IMXI | CTKB |
|---|---|---|
| Price | $12.11 | $5.30 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 2 | 4 |
| Target Price | ★ $15.00 | $5.63 |
| AVG Volume (30 Days) | 357.6K | ★ 838.9K |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.15 | N/A |
| Revenue | ★ $319,601,000.00 | $193,015,000.00 |
| Revenue This Year | $0.83 | $5.42 |
| Revenue Next Year | $1.49 | $7.03 |
| P/E Ratio | $84.13 | ★ N/A |
| Revenue Growth | 16.68 | ★ 17.67 |
| 52 Week Low | $11.15 | $3.28 |
| 52 Week High | $15.95 | $6.18 |
| Indicator | IMXI | CTKB |
|---|---|---|
| Relative Strength Index (RSI) | 30.23 | 67.07 |
| Support Level | $11.21 | $4.17 |
| Resistance Level | $14.77 | $5.24 |
| Average True Range (ATR) | 0.32 | 0.22 |
| MACD | -0.24 | 0.05 |
| Stochastic Oscillator | 7.33 | 90.18 |
International Money Express Inc is an omnichannel money remittance services company focused on the United States of America to Latin America and the Caribbean corridor, which includes Mexico, Central and South America and the Caribbean. The company offers wire transfer, money order, Foreign exchange, and cash checking services, while the majority of the revenue is derived from wire transfer and money order fees. The firm's business is organized around one reportable segment that provides money remittance services between the U.S. and Canada to Mexico, Guatemala, and other countries in Latin America, Africa, and Asia.
Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of research and clinical tools with its novel technical approach of leveraging the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its patented FSP technology optimizes sensitivity and accuracy through its optical and electronic designs that utilize an inventive method of light detection and distribution to a specifically selected number and type of detectors. Its FSP cell analyzers, the Cytek Aurora, Northern Lights, and Cytek Aurora Evo systems, deliver high-resolution, high-content and high-sensitivity cell analysis and address the inherent limitations of other technologies.